Anderson, Michelle A. E. http://orcid.org/0000-0003-1510-2942
Gonzalez, Estela http://orcid.org/0000-0002-4296-0080
Edgington, Matthew P. http://orcid.org/0000-0003-1922-9529
Ang, Joshua X. D.
Purusothaman, Deepak-Kumar http://orcid.org/0000-0003-4827-6519
Shackleford, Lewis
Nevard, Katherine http://orcid.org/0000-0002-1008-6587
Verkuijl, Sebald A. N. http://orcid.org/0000-0002-6771-0280
Harvey-Samuel, Timothy
Leftwich, Philip T. http://orcid.org/0000-0001-9500-6592
Esvelt, Kevin
Alphey, Luke http://orcid.org/0000-0002-2916-3802
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (N66001-17-2-4054, N66001-17-2-4054, N66001-17-2-4054, N66001-17-2-4054, N66001-17-2-4054, N66001-17-2-4054, N66001-17-2-4054, N66001-17-2-4054)
Wellcome Trust (110117/Z/15/Z, 110117/Z/15/Z, 110117/Z/15/Z)
RCUK | Biotechnology and Biological Sciences Research Council (BBS/E/I/00007033, BBS/E/I/00007038, and BBS/E/I/00007039, BBS/E/I/00007033, BBS/E/I/00007038, and BBS/E/I/00007039)
Article History
Received: 9 August 2023
Accepted: 11 January 2024
First Online: 25 January 2024
Competing interests
: L.A. is an adviser to Synvect Inc and Biocentis Ltd, with equity and/or financial interest in those companies. The other authors declare that they have no competing interests.